x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:14:12

Importance of Screening for HCC in HBV: Patient and...

Decera Clinical Education Infectious Disease Podcast ·

2022/04/12

In episode 7 of a series of sharing sessions between a physician and patient, Ming-Lung Yu, MD, PhD, and his patient, who is living with chronic hepatitis B, discuss:Role of family history in risk of hepatocellular carcinoma (HCC)Surveillance for HCCSteps to take when diagnosed with HCCHow to live a healthy life after HCC diagnosis and treatmentPresenter: Ming-Lung Yu, MD, PhDChair ProfessorHepatobiliary DivisionDepartment of Internal Medicine and Hepatitis CenterKaohsiung Medical UniversityVisiting

en

00:15:06

COVID-19: Which Drug, When, and Why?...

Decera Clinical Education Infectious Disease Podcast ·

2022/04/07

Anti-inflammatory agents and immunomodulators are key components to treating patients who are severely or critically ill due to a COVID-19 infection.In this episode, Vikramjit Mukherjee, MD, discusses the role and timing of these treatment options, including:High-titer convalescent plasmaCorticosteroidsInterleukin-6 inhibitors (eg, tocilizumab)Janus kinase inhibitors (eg, baricitinib)Presenter:Vikramjit Mukherjee, MDAssistant Professor of MedicineDivision of Pulmonary, Critical Care, & Sleep

en

00:42:19

Key Decisions in HIV Care: Managing ART With...

Decera Clinical Education Infectious Disease Podcast ·

2022/04/05

In this episode from the series “Key Decisions in HIV Care,” Cristina Mussini, MD, and William R. Short, MD, MPH, AAHIVS, discuss important considerations for ART with opportunistic infections, including: When to start ART with pneumocystis pneumonia including discussion of the ACTG 5164 study of immediate vs delayed ART with opportunistic infectionsEACS, DHHS, and IAS-USA guideline recommendations for starting ART in the setting of most opportunistic infectionsConsiderations for the administration

en

00:24:55

Hepatitis Delta a Major Global Problem: Screening,...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/30

In this episode, Heiner Wedemeyer, MD, discusses HDV epidemiology beyond the United States, the features of HDV/HBV pathology, insights into screening and diagnostic approaches, key aspects of disease staging, new treatment options, and important remaining clinical questions regarding optimal management of HDV.Presenter:Heiner Wedemeyer, MDProfessor and ChairmanDepartment of Gastroenterology, Hepatology and EndocrinologyHannover Medical SchoolHannover, GermanyContent based on an online CME program

en

00:18:27

The Ups and Downs of Living With HBV: Conversations...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/25

Episode 4 of this series features a conversation between a patient, Jason, and Paul Y. Kwo, MD, who discuss the particular challenges that can affect people with chronic hepatitis B seeking care in rural settings, including facing up to stigma, getting access to experienced medical practitioners, and searching for information and peer support.Presenter:Paul Y. Kwo, MDProfessor of MedicineDirector of HepatologyStanford University School of MedicinePalo Alto, CaliforniaContent based on an online CME

en

00:31:52

Key Decisions in HIV Care: PrEP Considerations in...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/25

In this episode from the series “Key Decisions in HIV Care,” Latesha Elopre, MD, MSPH, and Karine Lacombe, MD, PhD, discuss important considerations for PrEP in cisgender men and transgender women, including:Discussion of the PrEP gap and racial and gender disparities in PrEP access CDC, EACS, and WHO guidance on PrEP eligibility PrEP regimens currently recommended for adults and adolescents including FTC/TDF daily, FTC/TAF daily, and long-acting cabotegravir Data from clinical trials on the

en

00:38:55

Key Decisions in HIV Care: PrEP Considerations in...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/24

In this episode from the series “Key Decisions in HIV Care,” Latesha Elopre, MD, MSPH, and Karine Lacombe, MD, PhD, discuss important considerations for PrEP in cisgender women, including: Discussion of the PrEP gap and racial and gender disparities in PrEP accessCDC, EACS, and WHO guidance on PrEP eligibilityPrEP regimens currently recommended for adults and adolescents including FTC/TDF daily, FTC/TAF daily, and long-acting cabotegravirData from phase III trials on the efficacy of FTC/TDF daily

en

00:29:55

Lessons From Lockdown: HCC and Liver Transplant Care...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/23

In this episode, Graham R. Foster, FRCP, PhD, and Paul Y. Kwo, MD, share lessons learned in the management of HCC and liver transplantation the COVID-19 era, including:• Global impact of HCC and strategies for maintaining HCC care in the COVID-19 era• Characteristics of liver transplant recipients in the COVID-19 era• Impact of COVID-19 pandemic period on liver transplant outcomes• Impact of liver transplant status on COVID-19 outcomes• Strategies for providing streamlined care for patients with

en

00:13:23

Key Decisions in HIV Care: Considerations for...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/21

In this episode, Jason Schafer, PharmD, MPH, explores key considerations for the use of long-acting injectable pre-exposure prophylaxis (PrEP).- Listen as he gives his perspectives on:- The FDA approval of long-acting cabotegravir for PrEP- Healthcare professionals’ clinical concerns with long-acting injectable antiretroviral therapy- Considerations for long-acting cabotegravir as PrEPDosing and administrationManaging missed dosesDiscontinuationDelays in HIV diagnoses found in the HPTN 083 study in

en

00:21:20

Rational Use of New and Emerging Agents for Hepatitis...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/16

Hepatitis delta virus (HDV) is the most severe form of viral hepatitis and warrants new treatment options for better efficacy and tolerability. In part 2 of this 2-part podcast series, hear Heiner Wedemeyer, MD, and Cihan Yurdaydin, MD, discuss their thoughts on new and emerging treatment options for HDV and rational use of these new agents. Their discussion includes:Assembly inhibitors (eg, lonafarnib)Entry inhibitors (eg, bulevirtide)Interferon lambdaNucleic acid polymersSmall interfering RNA

en

00:18:10

Conference Conversations: HIV Advanced Practice...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/16

In this episode, Jeffrey Kwong, DNP, MPH, FAANP, FAAN, and Susan LeLacheur, DrPH, PA-C, AAHIVS, share insights on new HIV data from CROI 2022, including:Perinatal antiretroviral therapy exposureInvestigational formulation of long-acting contraception combined with pre-exposure prophylaxisMonitoring with long-acting cabotegravir for pre-exposure prophylaxisMyocardial infarction risk by HIV statusPresenters:Jeffrey Kwong, DNP, MPH, FAANP, FAANProfessorDivision of Advanced Nursing PracticeRutgers

en

01:41:42

HABP/VABP and Gram-Negative Resistance: Pathways to...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/15

In this episode, Keith S. Kaye, MD, MPH; Lilian Abbo, MD, FIDSA; and Jason M. Pogue, PharmD, discuss HABP/VABP and gram-negative resistance including:Epidemiology and burden of nosocomial bacterial pneumoniaPatient-specific risk factors for MDR pathogensImproving outcomes with the use of antibiogramsRecommended empiric therapy for clinically suspected VABPAntimicrobial resistance in HABP/VABPAlgorithms for gram-negative organism antibiotic-susceptibility testingUsing rapid diagnostic tests for

en

00:19:18

Conference Conversations: HIV Pharmacist Perspectives...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/15

In this episode, Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, share insights on new HIV data from CROI 2022, including:Islatravir tissue and plasma distribution after monthly oral dosingPharmacokinetics, safety, and acceptability of a tenofovir vaginal ringPrEP and Hormone Therapy in Transgender IndividualsAnticholinergic drug effects in older PWHAdherence in PWHPresenters:Fidelia Bernice, PharmDClinical Pharmacy Specialist, Infectious DiseasesDepartment of PharmacyUniversity of Maryland

en

00:34:41

Lessons From Lockdown: Viral Hepatitis Testing and...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/14

In this episode, Jordan J. Feld, MD, MPH, and Nancy Reau, MD, share lessons learned in the testing and treatment of viral hepatitis in the COVID-19 era, including:Global impact of the COVID-19 pandemic on viral hepatitis testing and linkage to careImpact of COVID-19 pandemic on testing and treatment in the United States and CanadaInnovative strategies to improve linkage to care of patients with viral hepatitis during the COVID-19 pandemicPresenters:Jordan J. Feld, MD, MPHProfessor of

en

00:46:40

Key HIV Studies Influencing My Practice Following...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/14

In this episode, Daniel R. Kuritzkes, MD, and David A. Wohl, MD, discuss new HIV data from CROI 2022, including:Prevention strategiesLA therapiesSecond-line therapiesThe VISEND study comparing dolutegravir-based antiretroviral therapy (ART) vs protease inhibitor–based ART for second-line therapyThe NADIA study comparing dolutegravir with darunavir/ritonavir and tenofovir disoproxil fumarate with zidovudine for second-line therapyComorbidities and cureACTG A5324 (InMIND) study of ART intensification

en

00:17:54

Key Decisions in HIV Care: ART Considerations in the...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/14

In this episode, Jason Schafer, PharmD, MPH, explores recommendations and data on managing antiretroviral therapy (ART) in the inpatient setting.Listen as he gives his perspectives on:Antiretroviral stewardship to prevent medication errors in the inpatient setting and at transitions of careRenal and hepatic dosing considerations for ARTDrug–drug interaction considerations between ART and medications commonly encountered in the inpatient settingAntiretroviral food effectsAdministration of

en

00:17:51

Key Decisions in HIV Care: Data on Long-Acting...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/14

In this episode, Jason Schafer, PharmD, MPH, explores the data for long-acting injectable pre-exposure prophylaxis (PrEP).Listen as he gives his perspectives on the:PrEP pipeline and the importance of having options for patients with differing preferencesFDA approval of long-acting cabotegravir for PrEPHPTN 083 and 084 studies of long-acting cabotegravir for PrEP compared with oral emtricitabine/tenofovir disoproxil fumarateSafety data on long-acting cabotegravir for PrEPCDC recommendations on the

en

00:20:50

Monitoring and Treating Patients Coinfected With HBV...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/10

Hepatitis delta virus (HDV) only exists in patients with hepatitis B virus (HBV) coinfection. In part 1 of this 2-part podcast series, hear Heiner Wedemeyer, MD, and Cihan Yurdaydin, MD, discuss their thoughts on serologic testing for both HDV and HBV and steps to take in monitoring, treating, and reassessing HBV in patients coinfected with HDV.Presenters:Heiner Wedemeyer, MDProfessor and ChairmanDepartment of Gastroenterology, Hepatology, and EndocrinologyHannover Medical SchoolHannover,

en

00:11:02

Starting HBV Treatment in Pregnancy: Conversations...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/07

Episode 3 of this series features Anna Cristina L. dela Cruz, MD, in conversation with patient Melody Cheng about Melody’s decision to start hepatitis B virus (HBV) antiviral therapy during pregnancy. This podcast also discusses recommended approaches to preventing HBV transmission from mother to child, current recommendations on starting treatment for chronic HBV infection, and the issues around stopping treatment.Presenter:Anna Christina L. dela Cruz, MDAssociate ProfessorDivision of Digestive

en

00:17:26

Hepatitis Delta Treatment: Where We Are and Where We...

Decera Clinical Education Infectious Disease Podcast ·

2022/03/03

Treatment options for hepatitis delta virus (HDV) are lacking, but many exciting agents are under investigation. Hear Drs Nancy Reau and Stefan Zeuzem discuss their thoughts on up-and-coming agents for treating HDV, and explore what questions need answering to most effectively use currently available and emerging therapies, which include:BulevirtideInterferon λLonafarnibPresenters:Nancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B

en

497 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College